+New session
traderby


The AI for Finance
Abbott Laboratories (ABT) is a United States-based medical devices and diagnostics company with shares or depositary interests associated with NASDAQ/NYSE. It sells diagnostics, cardiovascular devices, diabetes-care systems, nutrition products, and established medicines across hospital, laboratory, consumer, and emerging-market channels. Investors commonly compare it with LLY, NVO, PFE, UNH to evaluate sector exposure, business-model concentration, margin drivers, balance-sheet sensitivity, and how company-specific results may differ from broad equity benchmarks. The profile is intended as neutral issuer context for reviewing public-market exposure and related assets.
| Market | Return | Depth |
|---|---|---|